Today on the campaign trail the leaders talked tough on Trump's tariff war, thousands of people enrolled to vote and the ...

Promotional material for the upcoming David Hockney exhibition in Paris has been banned because the artist is seen with a ...

The Danish biotech’s recruitment drive began last summer when data from an early-stage trial of the drug—petrelintide—showed ...

Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, March 20, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a ...

Shares of pharmaceutical companies got hammered down in the Monday stock market meltdown amid the tariff war set in motion last week by the U.S. with its reciprocal tariffs. All 20 companies ...

Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, March 25, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a ...

Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity Initiated in December 2024, the Phase 2b ZUPREME-1 trial is ...

Copenhagen, Denmark, March 20, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide ...

After reiterating that he would be putting a 104 percent retaliatory tariff on China at 12:01 a.m. Wednesday, Trump said his administration would soon be tariffing pharmaceuticals too. ' ...

Speaking aboard Air Force One, Trump signalled a fresh approach to trade restrictions, stating that pharmaceuticals would be treated separately under the "Liberation Day" tariff plan. This contradicts ...

COPENHAGEN - Zealand Pharma A/S (NASDAQ:ZEAL), a Danish biotechnology firm with a market capitalization of $5.8 billion, has announced a nominal increase to its share capital following the ...